‘Cruel’ and ‘heartless’ Pharmac decisions rile breast cancer pressure group
+News
‘Cruel’ and ‘heartless’ Pharmac decisions rile breast cancer pressure group
New Zealand Doctor Rata Aotearoa
Tuesday 29 January 2019, 10:05 AM
Two petitions presented to MPs demanding Pharmac extend funding for Ibrance and Kadcyla cancer drugs have now gathered more than 42,000 signatures
Pharmac’s limitations on new drugs for breast cancer patients have provoked a lobby group backlash.
Breast Cancer Aotearoa Coalition (BCAC) chair L, Libby Burgess, Breast Cancer Aotearoa Coalition chair Libby Burgess called Pharmac limiting access to Ibrance “cruel” and “heartless”
Chemist Warehouse is sponsoring the Young Pharmacist of the Year Award in the 2025 New Zealand Primary Healthcare Awards | He Tohu Mauri Ora. The Chemist Warehouse leadership team explains what it means to be a Stellar Supporter